Physician profile

Emily Stege

Physician Assistant · Nampa, ID

NPI 1659801207

$5,905.77

in general payments reported to CMS, 2019-2025

40 companies · $1,873 in 2025

The $1,873 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).

See the full distribution for Physician Assistant

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,148.65
Education$216.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $1,386.29 2022-2025 Farxiga, Airsupra, Breztri
Abbvie INC. $907.66 2023-2025
Astellas Pharma US INC $474.52 2023-2024 Veozah
Lilly USA, LLC $436.17 2022-2025 Mounjaro, Zepbound, Jardiance
Glaxosmithkline, LLC. $433.39 2022-2024 Arexvy, Shingrix, Trelegy Ellipta
Novo Nordisk INC $301.94 2022-2025 Rybelsus, Wegovy, Ozempic
Tersera Therapeutics LLC $292.20 2024-2025 Quzyttir
Corcept Therapeutics $222.14 2024-2025 Korlym
Exact Sciences Corporation $166.05 2023-2025 Cologuard Collection Kit
Pfizer INC. $118.03 2023-2025
Abbott Laboratories $108.49 2025 Freestyle Libre 3
Lundbeck LLC $96.52 2024-2025 Vyepti, Rexulti
Amgen INC. $92.37 2024-2025 Otezla, Repatha, Repatha
Janssen Pharmaceuticals, INC $82.25 2023-2024 Xarelto, Spravato
Bayer Healthcare Pharmaceuticals INC. $57.52 2024
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Axsome Therapeutics, INC. $56.49 2025 Auvelity
Tris Pharma INC $54.78 2024-2025 Dyanavel Xr
Kowa Pharmaceuticals America, INC. $47.78 2025 Zoryve
Tolmar, INC. $44.81 2023-2024
Phathom Pharmaceuticals, INC. $42.22 2025 Voquezna
Sanofi-Aventis U.S. LLC $37.38 2025
Organon LLC $36.93 2025 Nexplanon
Azurity Pharmaceuticals, INC. $32.20 2025 Horizant, Azmiro
Collegium Pharmaceutical, INC. $31.63 2025 Jornay Pm
Idorsia Pharmaceuticals US INC $31.30 2023 Quviviq
Csl Behring $29.24 2025 Andembry
Otsuka America Pharmaceutical, INC. $28.01 2025 Rexulti
Biohaven Pharmaceutical Holding Company LTD. $27.67 2022
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $23.87 2023 Xifaxan
Edwards Lifesciences Corporation $23.51 2025 Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Inspire Medical Systems, INC. $22.28 2025 Inspire
Corium, LLC $20.27 2024-2025 Azstarys
Boehringer Ingelheim Pharmaceuticals, INC. $19.97 2025 Jardiance
Ironshore Pharmaceuticals INC. $19.75 2024
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $19.62 2025 Caplyta
Cranial Technologies, INC $18.84 2025 Doc Band
Dexcom, INC. $16.09 2024 Dexcom G6 Transmitter
Takeda Pharmaceuticals U.S.A., INC. $16.08 2024 Cuvitru
Supernus Pharmaceuticals, INC. $15.70 2025 Qelbree
Tandem Diabetes Care, INC. $13.81 2025 T:Slim X2 Insulin Pump With Control-Iq

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Emily Stege

$5,905.77

in general payments reported 2019-2025

Years
2022-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $1,873 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).

https://glasscript.com/doctor/11363183/emily-stege

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.